BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 17564566)

  • 41. [Cytomegaloviral infection in patients with hemoblastoses].
    Savchenko VG; Troitskaia VV; Misiurin AV; Parovichnikova VN; Isaev VG; Mendeleeva LP; Liubimova LS; Demidova IA; Aksenova EV; Filatov FP
    Ter Arkh; 2003; 75(7):52-8. PubMed ID: 12934482
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The use of sirolimus in ganciclovir-resistant cytomegalovirus infections in renal transplant recipients.
    Ozaki KS; Câmara NO; Nogueira E; Pereira MG; Granato C; Melaragno C; Camargo LF; Pacheco-Silva A
    Clin Transplant; 2007; 21(5):675-80. PubMed ID: 17845644
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation.
    Mori T; Mori S; Kanda Y; Yakushiji K; Mineishi S; Takaue Y; Gondo H; Harada M; Sakamaki H; Yajima T; Iwao Y; Hibi T; Okamoto S
    Bone Marrow Transplant; 2004 Feb; 33(4):431-4. PubMed ID: 14676775
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence for an increased rate of bacterial infections in liver transplant patients with cytomegalovirus infection.
    van den Berg AP; Klompmaker IJ; Haagsma EB; Peeters PM; Meerman L; Verwer R; The TH; Slooff MJ
    Clin Transplant; 1996 Apr; 10(2):224-31. PubMed ID: 8664524
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of targeted oral ganciclovir prophylaxis for transplant recipients of livers from cytomegalovirus-seropositive donors.
    Shah T; Lai WK; Mutimer D
    Transpl Infect Dis; 2005 Jun; 7(2):57-62. PubMed ID: 16150091
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The impact of pretransplant cytomegalovirus infection on acute renal allograft rejection.
    Chen JH; Mao YY; He Q; Wu JY; Lv R
    Transplant Proc; 2005 Dec; 37(10):4203-7. PubMed ID: 16387078
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value.
    Martín-Dávila P; Fortún J; Gutiérrez C; Martí-Belda P; Candelas A; Honrubia A; Barcena R; Martínez A; Puente A; de Vicente E; Moreno S
    J Clin Virol; 2005 Jun; 33(2):138-44. PubMed ID: 15911429
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute rejection episodes in pediatric renal transplant recipients with cytomegalovirus infection.
    Kranz B; Vester U; Wingen AM; Nadalin S; Paul A; Broelsch CE; Hoyer PF
    Pediatr Transplant; 2008 Jun; 12(4):474-8. PubMed ID: 18466436
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection.
    Reischig T; Jindra P; Svecová M; Kormunda S; Opatrný K; Treska V
    J Clin Virol; 2006 Jun; 36(2):146-51. PubMed ID: 16531113
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prospective study of relationship between cytomegalovirus pneumonia and viral load in renal transplant recipients.
    Ye Q; Luo G; He X; Zheng W; Zheng L; Dong X; Xu X; Nilsson-Ehle P; Xu N
    Transplant Proc; 2004 Dec; 36(10):3036-41. PubMed ID: 15686689
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Usefulness of urine and blood cultures for diagnosing cytomegalovirus infection in the kidney transplant recipient].
    Reina Prieto J; Bestard Palmer X; Saurina Gomila J; Gascó Company J; Fernández-Baca Gutiérrez del Alamo V; Munar Roca M
    Rev Clin Esp; 1998 Jan; 198(1):3-6. PubMed ID: 9534340
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytomegalovirus, human herpesvirus-6, and human herpesvirus-7 in adult liver transplant recipients: diagnosis based on antigenemia.
    Sampaio AM; Thomasini RL; Guardia AC; Stucchi RS; Rossi CL; Costa SC; Boin IF
    Transplant Proc; 2011 May; 43(4):1357-9. PubMed ID: 21620128
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Significance of reverse transcription polymerase chain reaction in the detection of human cytomegalovirus gene transcripts in thoracic organ transplant recipients.
    Lam KM; Oldenburg N; Khan MA; Gaylore V; Mikhail GW; Strouhal PD; Middeldorp JM; Banner N; Yacoub M
    J Heart Lung Transplant; 1998 Jun; 17(6):555-65. PubMed ID: 9662090
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of cytomegalovirus antigenemia and culture assays in patients on and off antiviral therapy.
    St George K; Rinaldo CR
    J Med Virol; 1999 Sep; 59(1):91-7. PubMed ID: 10440814
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytomegalovirus (CMV) glycoprotein B genotypes and response to antiviral therapy, in solid-organ-transplant recipients with CMV disease.
    Humar A; Kumar D; Gilbert C; Boivin G
    J Infect Dis; 2003 Aug; 188(4):581-4. PubMed ID: 12898447
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of quantitative PCR and antigenemia in cytomegalovirus infection in renal transplant recipients.
    Bordils A; Plumed JS; Ramos D; Beneyto I; Mascarós V; Molina JM; Cordoba J; García J; Crúz JM
    Transplant Proc; 2005 Nov; 37(9):3756-9. PubMed ID: 16386529
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of cytomegalovirus infection with human leukocyte antigen genotypes in recipients after allogeneic liver transplantation.
    Fan J; Meng XQ; Yang MF; Zhou L; Chen XM; Hu MJ; Fan WW; Ma WH; Li LJ
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):34-8. PubMed ID: 16481279
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of antigenemia assay and semiquantitative polymerase chain reaction test for monitoring active cytomegalovirus infection in allogeneic hematopoietic cell transplant recipients.
    Pajand O; Ziyaeyan M; Mousavi S; Fatolahzadeh B; Hojabri Z; Bahador A; Abdossamadi Z
    Exp Clin Transplant; 2008 Jun; 6(2):149-54. PubMed ID: 18816243
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
    McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A
    Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis.
    Reischig T; Jindra P; Hes O; Bouda M; Kormunda S; Treska V
    Transplantation; 2009 Feb; 87(3):436-44. PubMed ID: 19202451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.